Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin +/- Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial (ARTIST-II)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 May 2019
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ARTIST-II
- 17 May 2019 Planned primary completion date changed from 1 Jan 2016 to 1 Dec 2019.
- 17 May 2019 Status changed from recruiting to active, no longer recruiting.
- 15 Feb 2017 Planned End Date changed from 1 Jan 2016 to 1 Dec 2020.